| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/21/2001 | CN1322736A New polypeptide husan stat 2 gene 11 and its encoding polynucleotides |
| 11/21/2001 | CN1322735A New polypeptide human microglobulin transcription regulation factor 30 and its encoding polynucleotides |
| 11/21/2001 | CN1322732A New liver cancer up expressing gene and its encoded protein and application |
| 11/21/2001 | CN1322573A Bone-repairing material preparing method |
| 11/21/2001 | CN1322572A Transforming growth factor-beta gene vaccine as diabetes and nephropathy preventing preparation |
| 11/21/2001 | CN1322532A Application of staphyococcin Aureus in preparing medicine for osteoporosis |
| 11/21/2001 | CN1322526A Compound for treating female sexual dysfunction |
| 11/21/2001 | CN1075113C Realignment protein of human digestive enzyme and process for their preparation |
| 11/21/2001 | CN1075112C Producing process of HEV Protein and method of testing HEV infection |
| 11/21/2001 | CN1075078C Producing process of stem cell factor |
| 11/21/2001 | CN1075064C New benzoxazinedione derivatives, and producing process thereof and use |
| 11/21/2001 | CN1074932C Ophthalmic compositions |
| 11/21/2001 | CN1074926C Antiarrhythmic benzodiazepines |
| 11/20/2001 | US6320054 Thiazole derivatives |
| 11/20/2001 | US6320038 Promoter for neuropeptide FF and use thereof for therapy and diagnostics |
| 11/20/2001 | US6320037 IBD-associated microbial nucleic acid molecules |
| 11/20/2001 | US6320036 GbpA |
| 11/20/2001 | US6320029 Methods of production and use of liquid formulations of plasma proteins |
| 11/20/2001 | US6320026 Polypeptide for use in the prevention and treatment of tumors |
| 11/20/2001 | US6320024 Method for design of substances that enhance memory and improve the quality of life |
| 11/20/2001 | US6320023 Macrophage derived chemokine |
| 11/20/2001 | US6320022 Adrenomedullin peptides |
| 11/20/2001 | US6319907 Administering latency associated peptide, or a peptide analogue that is capable of maintaining transforming growth factor .beta. in latent state |
| 11/20/2001 | US6319906 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein |
| 11/20/2001 | US6319902 Peptide derivatives having thiazolyl-alanine residue |
| 11/20/2001 | US6319900 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 11/20/2001 | US6319899 Method and composition for the treatment of inflammatory bowel disease |
| 11/20/2001 | US6319897 Peptides which inhibit complement activation |
| 11/20/2001 | US6319896 Adding aqueous solution of charged polymer to solution of purified protein to reduce intermolecular or intramolecular interactions between the positively and negatively charged domains whereby solubility of protein is increased |
| 11/20/2001 | US6319895 Is disintegrated during transportation and does not adhere to the inner wall of oral cavity upon taking; hardness |
| 11/20/2001 | US6319894 Complexes and combinations of fetuin with therapeutic agents |
| 11/20/2001 | US6319893 Raising blood sugar level in hypoglycemic mammals by administering inhibitors of dipeptidyl peptidase IV |
| 11/20/2001 | US6319892 Administering recombinant myelin protein to alleviate t cell mediated autoimmune peripheral nervous system disease |
| 11/20/2001 | US6319891 Method of diagnosing and treating gliomas |
| 11/20/2001 | US6319890 Inhibition of binding of complement Factor H |
| 11/20/2001 | US6319726 Detecting intestinal defects; incubate body fluid with target antigen, allow binding, detect binding of antibodies, bound antibody indicates intestinal defect |
| 11/20/2001 | US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors |
| 11/20/2001 | US6319713 Methods and compositions for polypeptide engineering |
| 11/20/2001 | US6319703 Recombinant virus vectors |
| 11/20/2001 | US6319702 Nucleotide sequencs coding an enzymatic polypeptide and cell targeting compound; for use in treatment of cancer |
| 11/20/2001 | US6319701 Polypeptide; for use in the diagnosis, prevention, and treatment of cell proliferation, inflammation and immune response defects |
| 11/20/2001 | US6319700 Human choline acetyltransferase |
| 11/20/2001 | US6319693 Cloning of chicken anemia virus DNA |
| 11/20/2001 | US6319691 Fusion proteins comprising IFN-alpha2b and TM-alpha1 |
| 11/20/2001 | US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing |
| 11/20/2001 | US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1) |
| 11/20/2001 | US6319687 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene |
| 11/20/2001 | US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools |
| 11/20/2001 | US6319675 Methods for detecting and/or identifying agents which bind and/or modulate function of “bonzo” chemokine receptor |
| 11/20/2001 | US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 11/20/2001 | US6319662 Method and apparatus for removing viral contaminants from a body fluid |
| 11/20/2001 | US6319522 Growth-promoting agent |
| 11/20/2001 | US6319517 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation |
| 11/20/2001 | US6319510 Pad to be installed on gum comprising nonporous layer, adjacent layer retaining medication capable of being liquefied by saliva, semipermeable layer covering second layer and sealed to first layer to form pocket enclosing second layer |
| 11/20/2001 | US6319506 Method for treating hypercalcemia |
| 11/20/2001 | US6319505 Administering to patient suffering from tardive dyskinesia effective amount of botulinum toxin selected from types c, e, and g, thereby alleviating symptoms |
| 11/20/2001 | US6319504 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
| 11/20/2001 | US6319499 Administering amount of antibody or fragment thereof effective to activate endogenous activity of erythropoietin receptor in mammal, wherein antibody or fragment thereof interacts with peptide consisting of specified amino acid sequence |
| 11/20/2001 | US6319498 Amyloidogenic protein, or fragment thereof, modified with cis-decalin group, cholanoyl structure, cholyl group, diethylenetriaminepentaacetyl group, menthoxyacetyl group, fluorescein-containing group, or n-acetylneuraminyl group |
| 11/20/2001 | US6319495 Method for restoring glucose responsiveness to insulin secretion |
| 11/20/2001 | US6319493 Treatment of neoplastic disease with interleukin-10 |
| 11/20/2001 | US6319492 Copolymers of tyrosine-based polyarylates and poly(alkylene oxides) |
| 11/20/2001 | US6319468 Affinity binding-based system for detecting particulates in a fluid |
| 11/20/2001 | US6319192 Method for the treatment of fertility disorders |
| 11/20/2001 | CA2142557C Cytotoxic factor linked with multiple sclerosis and detection and quantitation thereof |
| 11/20/2001 | CA2077691C Oxidation resistant thrombomodulin analogs |
| 11/20/2001 | CA2065022C Rubella peptides |
| 11/20/2001 | CA2053864C Modified forms of reproductive hormones |
| 11/20/2001 | CA2018287C Use of rapamycin for preparing a composition for inhibiting organ or tissue transplant rejection, and composition for inhibiting transplant rejection |
| 11/20/2001 | CA2008116C Glycine derivatives |
| 11/20/2001 | CA1341320C Insulinotropic hormone |
| 11/19/2001 | CA2324167A1 A membrane-bound netrin |
| 11/18/2001 | CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 11/15/2001 | WO2001086003A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung |
| 11/15/2001 | WO2001086002A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 11/15/2001 | WO2001085984A1 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals |
| 11/15/2001 | WO2001085981A2 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
| 11/15/2001 | WO2001085980A2 Enzymatic assays for screening anti-cancer agents |
| 11/15/2001 | WO2001085964A2 Over expression of the whn protein |
| 11/15/2001 | WO2001085961A2 Human caspase-12 |
| 11/15/2001 | WO2001085959A2 Regulation of human lysostaphin-like protease |
| 11/15/2001 | WO2001085956A2 Lipid metabolism enzymes |
| 11/15/2001 | WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 11/15/2001 | WO2001085953A1 Sphingosine kinase and uses thereof |
| 11/15/2001 | WO2001085949A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 11/15/2001 | WO2001085947A2 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 11/15/2001 | WO2001085942A2 Cytoskeleton-associated proteins |
| 11/15/2001 | WO2001085940A2 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS |
| 11/15/2001 | WO2001085938A1 Modified es cells and es cell-specific gene |
| 11/15/2001 | WO2001085936A1 F-box containing protein |
| 11/15/2001 | WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 11/15/2001 | WO2001085933A2 Plakoglobin interacting proteins |
| 11/15/2001 | WO2001085931A2 Polypeptide inhibiting a proton-gated na+ channel |
| 11/15/2001 | WO2001085930A2 Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| 11/15/2001 | WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 11/15/2001 | WO2001085924A2 MODULATION OF η-SECRETASE ACTIVITY |
| 11/15/2001 | WO2001085923A1 A novel polypeptide, a human atp dependent serine hydrolase 9.2 and the polynucleotide encoding the polypeptide |
| 11/15/2001 | WO2001085920A2 Compositions and methods for producing antigen-presenting cells |
| 11/15/2001 | WO2001085912A2 Presenilin enhancers |
| 11/15/2001 | WO2001085911A2 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes |